Author

Anderson S. Peck

Van Andel Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:imaging· 1 Organism:mouse· 1

Frequent Co-Authors

Abhay Gupta· 1 shared Adrian M. BebenekiD· 1 shared Chad R. HaneyiD· 1 shared Clarissa Valdez· 1 shared Daniel L. KranziD· 1 shared Emily Alexandria WatersiD· 1 shared Kirsten L. ViolaiD· 1 shared Maira Assunção BiccaiD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Abhay Gupta

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The therapeutic and diagnostic potential of amyloid β oligomers (AβOs) selective antibodies to treat Alzheimer's disease

Kirsten L. Viola, Maira Assunção Bicca, Adrian M. Bebenek, Daniel L. Kranz, Vikas Nandwana, Emily Alexandria Waters, Chad R. Haney, Maxwell Y Lee, Abhay Gupta, Zachary Brahmbhatt, Weijian Huang, Ting-Tung A. Chang, Anderson S. Peck, Clarissa Valdez, Vinayak P. Dravid, William L. Klein

This paper demonstrates that amyloid β oligomers (AβOs) are key drivers of Alzheimer's disease pathology and shows that AβO-selective antibodies can restore memory function and serve as diagnostic tools.

Frontiers in Neuroscience · Jan 3, 2022Peer-reviewedNeuroscience